Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rudolf

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Pharmacology|December 28, 1999
BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonistH Doods, W Gaida, H A Wieland, et al.
Regulatory Peptides|August 27, 1996
BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological propertiesH N Doods, H A Wieland, W Engel, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226H A Wieland, K D Willim, M Entzeroth, et al.
European Journal of Pharmacology|June 18, 1997
Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulationH Racchi, A J Schliem, M V Donoso, et al.
European Journal of Pharmacology|May 24, 1995
Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226M Entzeroth, H Braunger, W Eberlein, et al.
Molecular Pharmacology|August 1, 1996
Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptorM Sautel, K Rudolf, H Wittneben, et al.
European Journal of Pharmacology|December 27, 1994
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226K Rudolf, W Eberlein, W Engel, et al.
Life Sciences|January 1, 1993
Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacologyH N Doods, R Quirion, G Mihm, et al.
Human Reproduction (Oxford, England)|September 2, 1999
The outcome of intracytoplasmic sperm injection in patients with retrograde ejaculationN Nikolettos, S Al-Hasani, V Baukloh, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 26, 2005
PYY3-36 as an anti-obesity drug targetM M Boggiano, P C Chandler, K D Oswald, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Pharmacology|December 28, 1999
BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonistH Doods, W Gaida, H A Wieland, et al.
Regulatory Peptides|August 27, 1996
BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological propertiesH N Doods, H A Wieland, W Engel, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226H A Wieland, K D Willim, M Entzeroth, et al.
European Journal of Pharmacology|June 18, 1997
Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulationH Racchi, A J Schliem, M V Donoso, et al.
European Journal of Pharmacology|May 24, 1995
Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226M Entzeroth, H Braunger, W Eberlein, et al.
Molecular Pharmacology|August 1, 1996
Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptorM Sautel, K Rudolf, H Wittneben, et al.
European Journal of Pharmacology|December 27, 1994
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226K Rudolf, W Eberlein, W Engel, et al.
Life Sciences|January 1, 1993
Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacologyH N Doods, R Quirion, G Mihm, et al.
Human Reproduction (Oxford, England)|September 2, 1999
The outcome of intracytoplasmic sperm injection in patients with retrograde ejaculationN Nikolettos, S Al-Hasani, V Baukloh, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 26, 2005
PYY3-36 as an anti-obesity drug targetM M Boggiano, P C Chandler, K D Oswald, et al.
Pageof 11